Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes chronic inflammation and ulcers in the innermost ...

While there’s no one-size-fits-all approach for managing ulcerative colitis, experts say you may not need to avoid these ...

Takeda (TSE:4502/NYSE:TAK) today announced positive data from the pivotal Phase 3 KEPLER trial, which demonstrated that ENTYVIO® (vedolizumab) can offer the possibility of clinical remission for ...

Phase 3 results suggest intravenous vedolizumab is effective and safe for clinical remission in pediatric patients with moderate to severe UC.

Ulcerative colitis, a form of IBD, can change how your stool looks, smells, and feels. Learn what UC poop looks like during a ...

In the RELIEVE UCCD LTE phase 2b study, duvakitug showed robust, durable efficacy for an additional 44 weeks in UC and CD patients who had responded after 14 weeks of inductionDuvakitug was well ...

A new study suggests that combining routine stool tests and tracking habitual dietary patterns could help to predict IBD flares.

A large-scale study shows that combining AI with statistical modeling can predict which ulcerative colitis patients with ...

NImmune Biopharma ("NImmune"), a private late-stage precision inflammation and immunology ("I&I") biopharmaceutical company, today announced that Executive Chairman, President and CEO Dr. Josep ...

Stress is an inevitable part of life, but it can impact everyone differently. In patients with ulcerative colitis, stress is a trigger that can lead to flares and worsening symptoms. That means ...

Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s ...